Ibuprofen Max Laboratoria Polfałódź

Ibuprofen, the active ingredient in Ibuprofen Max Laboratoria Polfałódź, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It treats pain, fever and inflammation in adults and children as appropriate.

GNH USA supplies Ibuprofen Max Laboratoria Polfałódź as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces pain, fever, and inflammation by inhibiting cyclooxygenase enzymes.

- Pain: provides relief from mild to moderate acute pain such as headache, dental pain, or musculoskeletal discomfort. - Fever: lowers elevated body temperature associated with infections or inflammatory conditions. - Inflammation: decreases swelling and tenderness in conditions like arthritis or soft‑tissue injuries.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Renal impairment or acute kidney injury. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Cardiovascular events: increased risk of thrombotic complications.

Before using ibuprofen, consider the following safety measures.

- Assess renal function: adjust use in patients with existing kidney disease. - Evaluate gastrointestinal risk: avoid in individuals with a history of ulcers or bleeding. - Review concomitant anticoagulant therapy: increased bleeding potential. - Use cautiously in asthma: may provoke bronchospasm. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ibuprofen may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): increased hemorrhagic potential. - Lithium: ibuprofen can raise serum lithium concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: combined use may impair kidney perfusion. - Methotrexate: ibuprofen may decrease clearance, raising toxicity risk.